Suppr超能文献

孕期感染新型冠状病毒2(SARS-CoV-2)突破性感染优先引发IgG4反应并增强胎盘转运。

SARS-CoV-2 breakthrough infection during pregnancy preferentially elicits IgG4 response and enhanced placental-transfer.

作者信息

Wagner Sheridan B, Rincon Monica, Keen Katelyn E, Hawk Gregory S, Marshall Nicole E, Messaoudi Ilhem

机构信息

Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY, United States.

Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, United States.

出版信息

Vaccine. 2025 Jul 9;62:127476. doi: 10.1016/j.vaccine.2025.127476.

Abstract

BACKGROUND

Emerging SARS-CoV-2 variants and waning humoral immunity have led to increased occurrences of breakthrough infection. Pregnant individuals and neonates are particularly vulnerable to adverse outcomes associated with COVID-19.

OBJECTIVE

We aimed to evaluate the maternal anti-SARS-CoV-2 IgG response and the placental transfer of antibodies to the fetus following breakthrough infection, infection in unvaccinated participants, and vaccination in the absence of infection during pregnancy.

METHODS

Pregnant patients (n = 165) were enrolled at Oregon Health & Science University and assigned to three cohorts based on infection and vaccination status. Receptor-binding domain (RBD) and nucleocapsid protein (NP) specific IgG endpoint titers (EPT) and optical density (OD) values were determined via ELISA longitudinally in maternal blood and breastmilk, and at delivery in paired maternal, umbilical cord, and newborn blood.

RESULTS

Breakthrough infection in vaccinated participants induced a higher maternal RBD-specific IgG response compared to infection or vaccination alone in maternal plasma and breastmilk. As reported with repeated vaccination, breakthrough infection skewed RBD-specific IgG responses toward an IgG4 response. IgG1 and IgG3 were the dominant NP-specific subclasses for both breakthrough infection and unvaccinated/infection groups. The breakthrough infection cohort had the highest newborn-to-maternal ratio of RBD-specific IgG with a strong correlation between maternal and newborn delivery titers.

CONCLUSION

Breakthrough infection during pregnancy prolongs pre-existing humoral immunity and facilitates the transplacental transfer of antibodies to the neonate, reflecting an antibody priming effect induced by prior vaccination rather than infection alone. These results warrant continued administration of updated SARS-CoV-2 vaccination during pregnancy to reduce disease severity and provide greater protection to newborns.

摘要

背景

新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的出现以及体液免疫的减弱导致突破性感染的发生率增加。孕妇和新生儿尤其容易受到与2019冠状病毒病(COVID-19)相关的不良后果的影响。

目的

我们旨在评估突破性感染、未接种疫苗参与者感染以及孕期未感染情况下接种疫苗后母体抗SARS-CoV-2 IgG反应以及抗体向胎儿的胎盘转运情况。

方法

俄勒冈健康与科学大学招募了165名孕妇患者,并根据感染和疫苗接种状况将其分为三个队列。通过酶联免疫吸附测定法(ELISA)纵向测定母体血液和母乳中以及分娩时配对的母体、脐带和新生儿血液中受体结合域(RBD)和核衣壳蛋白(NP)特异性IgG终点滴度(EPT)和光密度(OD)值。

结果

与单独感染或接种疫苗相比,接种疫苗的参与者发生突破性感染时,母体血浆和母乳中诱导产生的RBD特异性IgG反应更高。如重复接种疫苗时所报道的那样,突破性感染使RBD特异性IgG反应偏向IgG4反应。对于突破性感染组和未接种疫苗/感染组,IgG1和IgG3是主要的NP特异性亚类。突破性感染队列中新生儿与母体的RBD特异性IgG比率最高,母体和新生儿分娩时的滴度之间具有很强的相关性。

结论

孕期突破性感染可延长先前存在的体液免疫,并促进抗体经胎盘转运至新生儿,这反映了先前接种疫苗而非单纯感染所诱导的抗体启动效应。这些结果表明在孕期应持续接种更新的SARS-CoV-2疫苗,以降低疾病严重程度并为新生儿提供更好的保护。

相似文献

3
Placental transfer of SARS-CoV-2 antibodies in mother-neonate pairs: a prospective nested cohort study.
BMC Infect Dis. 2025 Jul 1;25(1):875. doi: 10.1186/s12879-025-11225-6.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
9
Concordance of maternal and cord blood SARS-COV-2 immunoglobulin seropositivity after COVID-19 infection or vaccination in pregnancy.
J Neonatal Perinatal Med. 2025 Jan;18(1):9-17. doi: 10.1177/19345798251315385. Epub 2025 Feb 5.
10
Maternal and Placental Antibody Responses in SARS-CoV-2 Vaccination and Natural Infection During Pregnancy.
Pediatr Infect Dis J. 2025 Feb 1;44(2S):S32-S37. doi: 10.1097/INF.0000000000004704. Epub 2025 Feb 14.

本文引用的文献

3
COVID-19 in Pregnancy: An Update for Clinicians.
Clin Obstet Gynecol. 2024 Sep 1;67(3):565-575. doi: 10.1097/GRF.0000000000000885. Epub 2024 Jul 5.
4
Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness.
Viruses. 2024 Jan 25;16(2):184. doi: 10.3390/v16020184.
5
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants.
Pediatrics. 2024 Mar 1;153(3). doi: 10.1542/peds.2023-064252.
7
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.
Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023.
8
The unique properties of IgG4 and its roles in health and disease.
Nat Rev Immunol. 2023 Nov;23(11):763-778. doi: 10.1038/s41577-023-00871-z. Epub 2023 Apr 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验